The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes

Annals of Intensive Care
Marco CrismanJohan Mårtensson

Abstract

In critically ill patients with permissive hyperglycemia, it is uncertain whether exogenous insulin administration suppresses or enhances c-peptide secretion (a marker of pancreatic beta-cell response). We aimed to explore this effect in patients with type 2 diabetes. We prospectively enrolled a cohort of 45 critically ill patients with type 2 diabetes managed according to a liberal glucose protocol (target blood glucose 10-14 mmol/l). We recorded the administration of insulin and oral hypoglycemic agents and measured plasma c-peptide as surrogate marker of endogenous insulin secretion on the first two consecutive days in ICU. Overall, 20 (44.4%) patients required insulin to achieve target blood glucose. Insulin-treated patients had higher glycated hemoglobin A1c, more premorbid insulin-requiring type 2 diabetes, and greater blood glucose levels but lower c-peptide levels on admission. Premorbid insulin-requiring diabetes was independently associated with lower admission c-peptide, whereas greater plasma creatinine was independently associated with higher levels. Increases in c-peptide were positively correlated with an increase in blood glucose both in patients who did (r = 0.54, P = 0.01) and did not (r = 0.56, P = 0.004) rec...Continue Reading

References

Aug 1, 1987·Diabetes·G M ArgoudR P Eaton
Mar 1, 1985·The Journal of Clinical Endocrinology and Metabolism·W T GarveyJ M Olefsky
May 20, 1982·The New England Journal of Medicine·D ElahiR Andres
Jun 17, 2004·Experimental Diabesity Research·John WahrenHans Jörnvall
Nov 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Anders ThorellOlle H Ljungqvist
Apr 7, 2007·Critical Care Medicine·Michael G VishBasilia Zingarelli
Aug 2, 2007·The Journal of Clinical Endocrinology and Metabolism·Lies LangoucheGreet Van den Berghe
Mar 15, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ranjit S ChimaBasilia Zingarelli
Jan 26, 2012·Diabetes·Mark J Holness, Mary C Sugden
Mar 14, 2012·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Christina BlixtOlav Rooyackers
Feb 19, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·A G Jones, A T Hattersley
Mar 5, 2013·Critical Care : the Official Journal of the Critical Care Forum·James S KrinsleyRinaldo Bellomo
Nov 17, 2015·Critical Care : the Official Journal of the Critical Care Forum·Signe Tellerup NielsenKirsten Møller
Mar 16, 2016·Critical Care Medicine·Nora LuethiRinaldo Bellomo
Sep 17, 2016·Critical Care : the Official Journal of the Critical Care Forum·Nora LuethiJohan Mårtensson

❮ Previous
Next ❯

Citations

Mar 7, 2018·Critical Care Medicine·Nora LuethiJohan Mårtensson

❮ Previous
Next ❯

Software Mentioned

STATA
/ SE

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.